Fact CheckerSign in

NCT04993612Recruiting

Postcapillary Blood Gas Analysis in Wedge Position (Wedge-BGA)

Blood Gas Analysis Obtained in Pulmonary Capillary Wedge Position During Right Heart Catheterization

Source: ClinicalTrials.gov · Last updated 6 Feb 2026

Brief summary (registry, in English)

If pulmonary hypertension is suspected, a right heart catheterization is usually performed to confirm or rule out the diagnosis. As part of this examination, blood samples are taken from various locations as standard and blood gas analyses are performed. One of the most important measurements during the right heart catheterization is the measurement of the pulmonary arterial occlusion pressure by the so-called wedge maneuver. To measure this value, the catheter with inflated balloon must be advanced into the pulmonary vessels until the "wedge" position is reached, i.e. the balloon completely occludes a branch of the pulmonary artery. In this study, the investigators want to characterize patients with pulmonary hypertension of different causes in more detail. To do that, two blood samples (totaling approximately 4 mL of blood, one sample directly after occlusion and the other one two minutes later) will be drawn during the right heart catheterization from the above-mentioned "wedge" position", behind the inflated balloon, and blood gas analyses will be performed on these samples. In addition, various clinical parameters (comorbidities, etc.) will be recorded by means of clinical questionnaires. Follow-up data will be analyzed and correlations with the aforementioned blood gas analyses will be examined. The results of the study will be used to more precisely characterize the still vague concept of secondary pulmonary hypertension. This could help to develop new therapeutic strategies in some subgroups in the future.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
30 Jul 2021
Start date
25 Jun 2021
Primary completion date
30 Jun 2026
Lead sponsor
Ayham Daher
NCT number
NCT04993612

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 25 Jun 2021 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Individuals who are not fully capable of giving consent and understanding the nature, significance, and scope of the study
  • Pregnancy and lactation
  • Wedge-BGA not possible

Who the study is looking for

  • Patients who have a clearly defined indication for Right heart catheterization.
  • Age \> 18 years
  • Informed consent for participation in the study will sign

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Rwth Aachen
Coordinator of this site? Confirm its status
AachenGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.